BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

News   Oct 23, 2012

 
BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
 
 
 

RELATED ARTICLES

Tapeworm Drug Molecule Could Aid Fight Against Parkinson’s Disease

News

Researchers have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's disease.

READ MORE

Searching for the CRISPR Swiss-army Knife

News

High-resolution structural comparison of Cpf1 and Cas9 could help researchers achieve more accurate gene editing with CRISPR.

READ MORE

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE